Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis

Cytokine. 2012 Mar;57(3):305-12. doi: 10.1016/j.cyto.2011.12.005. Epub 2011 Dec 30.

Abstract

Rheumatoid arthritis (RA) is an inflammatory disease is one of the most serious medical problems, affecting ∼1% of all people worldwide, irrespective of race. The disease is autoimmune in nature and characterized by chronic inflammation of the synovial tissues in multiple joints that leads to joint destruction. Although T cells are central players in RA development, B cells are required for full penetrance of disease largely via their production of autoantibodies against Fc domain of IgG rheumatoid factor (RF). Treatment options for RA are limited and if any, are inadequate due to associated side effects. Members of the tumor necrosis factor (TNF) superfamily play important roles in a number of autoimmune diseases, including RA. In this review, we briefly summarize key features of the superfamily, we will consider how the well-characterized members concerned with immune regulation are coordinated and their roles in rheumatoid arthritis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antigens, CD / metabolism
  • Arthritis, Rheumatoid / therapy*
  • Humans
  • Molecular Targeted Therapy*
  • Tumor Necrosis Factor Inhibitors*
  • Tumor Necrosis Factors / metabolism

Substances

  • Antigens, CD
  • Tumor Necrosis Factor Inhibitors
  • Tumor Necrosis Factors